Ontology highlight
ABSTRACT:
ORGANISM(S): Mus musculus
SUBMITTER: Li Li
PROVIDER: E-GEOD-32316 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
Science translational medicine 20111201 113
Clinical use of recombinant fibroblast growth factor 21 (FGF21) for the treatment of type 2 diabetes and other disorders linked to obesity has been proposed; however, its clinical development has been challenging owing to its poor pharmacokinetics. Here, we describe an alternative antidiabetic strategy using agonistic anti-FGFR1 (FGF receptor 1) antibodies (R1MAbs) that mimic the metabolic effects of FGF21. A single injection of R1MAb into obese diabetic mice induced acute and sustained ameliora ...[more]